Related Experiment Video
Updated: Jul 13, 2026

Synthesis and Purification of Iodoaziridines Involving Quantitative Selection of the Optimal Stationary Phase for Chromatography
Published on: May 16, 2014
Theoretical optimization and validation of Iodine-123 and Iodine-124 production via tellurium and antimony targets
Maher T Saad1, Duaa Abed Salim2
1Ministry of Education, Directorate of Education, Baghdad, Alkarkh-3, Iraq.
Abstract:
Using various theoretical models within TALYS-2.0, we computed excitation functions, thick-target yields at EOB and 12-h post-EOB impurity analysis. Models were selected for each reaction route using statistical analysis to define practical energy windows that balance production yield and radionuclidic purity. For 123I, Te(p,xn) dominates: 123Te(p,n), 124Te(p,2n), and 125Te(p,3n) gave calculated yields of 162, 570, and 990 MBq/μA·h within the selected 13 → 10, 26 → 21, and 38 → 30 MeV windows, respectively. Among these routes, 123Te(p,n) is favored when lower proton-energy operation and impurity control are prioritized, with 124I limited to only 0.05% when enriched 123Te is used. For 124I, 125Te(p,2n) gave the largest calculated yield, 43.5 MBq/μA·h within 19 → 16 MeV, whereas 124Te(p,n) gave 21.3 MBq/μA·h within 12 → 8 MeV with better impurity control, showing limited 125I and 123I impurities of 0.03% and 0.81%, respectively. Deuteron- and alpha-induced routes were generally less favorable because of lower yields, larger impurity contributions, or more demanding irradiation conditions. The evaluation of model performance revealed that global nucleon level density and optical models (e.g., GSM, SHFB, BFM, G-OMP) reliably reproduced cross sections for proton-induced processes, attaining R2 values exceeding 0.93. Local deuteron potentials (DP Han, DP Haixia) are essential for the accurate examination of specific deuteron reactions, while α-optical potentials (Avrigeanu, Demetriou, Nolte) are vital for reactions that involve multi-neutron emissions on Sb. Overall, enriched Te(p,xn) remains the preferred clinical route.

